Bruce J. Kinon, MD

Karuna Therapeutics, Boston, Massachusetts; Corresponding Author: Bruce J. Kinon, MD ([email protected]), c/o Alicia Meli, MS, Bristol Myers Squibb Corporate Headquarters, Route 206 & Province Line Road, Princeton, NJ 08543

JCP
Adjunctive Treatment Targeting Multiple Mechanisms in Schizophrenia
JCP
JCP
JCP
JCP
JCP
JCP
JCP
JCP
JCP
JCP
JCP